Purchase Order 75F40119P10665
- Not listed
- This is a $428,940.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Toxstrategies, LLC, a small business based in Austin, Texas. The primary purpose of the contract is to acquire a hazard and risk assessment protocol that requires special consideration for unique biological characteristics that may impact the evaluation of ingredients in cosmetic products. This contract has a total small business set-aside designation. Toxstrategies is a multidisciplinary...
- This contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Ama Analytical Services, Inc., a small business prime contractor, to provide talc testing services. The $211,200.00 firm-fixed-price purchase order was awarded on September 20, 2019 and has a completion date of September 29, 2022. Ama Analytical Services is a for-profit, subchapter S corporation based in Berwyn Heights, Maryland that specializes in asbestos, lead, mold, and nano...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Ama Analytical Services, Inc., a small business located in Lanham, Maryland. The $794,470 contract is for testing official samples of talc-containing cosmetics for asbestiform particles. The contract has a period of performance ending on September 13, 2027. This contract is not associated with a larger contract vehicle and does not have a set-aside designation. Ama Analytical Services, Inc. is a...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Ama Analytical Services, Inc., a small business based in Lanham, Maryland. The contract is for $88,200.00 and covers the testing of official samples of talc-containing cosmetics for asbestiform fibers. The original solicitation was set aside for small businesses under NAICS code 541380 (Testing Laboratories). Ama Analytical Services specializes in environmental testing services,...
- This federal contract award, valued at $18,566,814.06, was issued by the Office of Chemical Safety and Pollution Prevention (a civilian agency) to prime contractor Research Triangle Institute (RTI International), a non-profit research organization. The contract provides technical support for the development and implementation of pathway-based systematic reviews, a universe of chemicals, and a scientific IT platform. No set-aside designation was used. Toxstrategies, LLC, a for-profit scientific...
- This federal contract award provides small molecules and biologics toxicology consultant support services to the National Institute on Drug Abuse (NIDA), a civilian agency. The $28,000.00 purchase order contract was awarded to Toxstrategies, LLC, a for-profit small business, on September 22, 2025 with a completion date of September 21, 2028. The work is to be performed in Katy, Texas. The original solicitation was a pre-solicitation notice from the National Institute of Neurological Disorders...
- This is a $897,471 firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), doing business as Inhalation Toxicology Research Institute. The contract is part of a larger In Vivo Toxicology of Tobacco 2015-2020 indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. LBERI, a non-profit contract research organization, will provide preclinical research services to support the...
- This is a $131,760.00 firm fixed-price delivery order awarded by the Consumer Product Safety Commission (CPSC), a civilian federal agency, to Toxicology Excellence for Risk Assessment (TERA), a non-profit organization. The contract is for risk assessment services under the CPSC's SEEK CONTRACTOR FOR CHEMICAL RESEARCH program. The contract has a period of performance through September 28, 2016 and does not utilize a set-aside designation. No additional details about potential larger contract...
- This is a firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization, to conduct in vitro evaluation of the toxic profiles of tobacco additives in a systematic tiered approach. The contract has a ceiling value of $1,552,162.00 and an ultimate completion date of July 14, 2018. It was issued under the FDA's "In Vivo Toxicology of Tobacco...
- This is a firm-fixed-price purchase order contract awarded by the National Library of Medicine, a civilian agency, to Toxicology Excellence For Risk Assessment (TERA) for a leasing arrangement for a toxicity database. The contract, valued at $210,000.00, was awarded on January 7, 2012 and had a completion date of January 6, 2017. There was no set-aside designation for this award. As the National Library of Medicine is part of the Department of Health and Human Services, this contract likely...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Toxstrategies, LLC, a small business based in Austin, Texas. The contract is for a "TALC REVIEW" with a potential value of $193,500.00 and a completion date of April 1, 2021. The contract was awarded on a total small business set-aside basis in response to a solicitation posted on August 28, 2019, with proposals due by September 6, 2019. Toxstrategies is a multidisciplinary scientific consulting firm that provides toxicology and related services to federal agencies including the FDA, National Institutes of Health, and Department of Justice. This contract likely involves Toxstrategies providing technical expertise and assessments related to the review of talc, which is an ingredient used in various FDA-regulated products.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Scoping review and systematic review of cosmetic talc use | FDARFQ1214205 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/1 | 8/28/19, 1:17 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Close Out | ($149k) | 9/22/21 | |
| P00002 | Other Administrative Action | $0 | 4/1/20 | |
| P00001 | Exercise an Option | $196.3k | 2/13/20 | |
| Not listed | Not listed | $146.5k | 9/18/19 |